SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041741
Filing Date
2019-11-07
Accepted
2019-11-07 16:12:02
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20190930.htm 10-Q 3005137
2 EX-31.1 adro-ex311_6.htm EX-31.1 17203
3 EX-31.2 adro-ex312_9.htm EX-31.2 17127
4 EX-32.1 adro-ex321_10.htm EX-32.1 8138
  Complete submission text file 0001564590-19-041741.txt   9656130

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT adro-20190930.xml EX-101.INS 2140780
6 XBRL TAXONOMY EXTENSION SCHEMA adro-20190930.xsd EX-101.SCH 59539
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20190930_cal.xml EX-101.CAL 74773
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20190930_def.xml EX-101.DEF 203227
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20190930_lab.xml EX-101.LAB 502989
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20190930_pre.xml EX-101.PRE 383286
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 191200455
SIC: 2834 Pharmaceutical Preparations